SCHEMBL4377583

SCHEMBL4377583

O=C(CSc1ccc2ccccc2c1)N1CCN(c2ccncc2)CC1

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.77
KDM4E B2RXH2 3/20 0.77
GAA P10253 2/20 0.77
TDP1 Q9NUW8 2/20 0.77
ATM Q13315 1/20 0.77
L3MBTL1 Q9Y468 1/20 0.77
SMN1; SMN2 Q16637 3/20 0.61
HPGD P15428 2/20 0.61
ALDH1A1 P00352 9/20 0.55
LMNA P02545 5/20 0.55
HSD17B10 Q99714 2/20 0.54
STAT3 P40763 1/20 0.53
POLB P06746 1/20 0.52
TSHR P16473 1/20 0.52
USP2 O75604 1/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MAPK1 P28482 1/20 0.49
RGS12 O14924 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4379070 0.82 KDM4E (0.76) MAPTKDM4EGAATDP1ATM
SCHEMBL4378297 0.81 LMNA (0.61) MAPTKDM4EGAAL3MBTL1SMN1; SMN2
SCHEMBL4612761 0.79 SMN1; SMN2 (0.61) MAPTKDM4EGAATDP1ATM
SCHEMBL4377409 0.79 MEN1 (0.75) MAPTKDM4EGAAHPGDALDH1A1
SCHEMBL14218059 0.78 KMT2A (0.67) MAPTKDM4EGAATDP1ATM
SCHEMBL4379550 0.75 ALDH1A1 (0.51) MAPTKDM4EGAATDP1ATM
SCHEMBL4377257 0.75 RAB9A (0.75) MAPTKDM4EGAATDP1ATM
SCHEMBL4378474 0.75 KDM4E (0.61) MAPTKDM4EGAATDP1ATM
SCHEMBL6786506 0.74 F10 (0.60) KDM4EGAAATMSMN1; SMN2ALDH1A1
SCHEMBL4380926 0.74 KDM4E (0.60) MAPTKDM4EGAATDP1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP claimed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 MAPT 1441/4885KDM4E 1567/4885GAA 2830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.